According to filings with the U.S. Securities and Exchange Commission, Intelligent Bio Solutions is raising up to $10,100,683.00 in new funding. Sources indicate that as part of senior management Chief Financial Officer, Spiro Sakiris played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Intelligent Bio Solutions
Intelligent Bio Solutions is on a mission to redefine the approach to testing and deliver pain-free, accessible solutions that drive transformative change and improve the quality of life. We’re a medical technology company delivering intelligent, rapid, non-invasive testing solutions. Our Intelligent Fingerprinting Drug Screening System is revolutionizing portable testing through fingerprint sweat analysis, which has the potential for broader applications in additional fields. This highly accurate, hygienic, and cost-effective system screens for recent use of drugs commonly found in the workplace, including opiates, cocaine, methamphetamine, and cannabis. With sample collection in seconds and results in under ten minutes, our technology would be a valuable tool for employers in safety-critical industries. Additionally, our biosensor platform has the potential to test for up to 130 indications, ranging from glucose to immunological conditions and communicable diseases. Our current customer segments include construction, manufacturing and engineering, transport and logistics firms, drug treatment organizations, and coroners.

To learn more about Intelligent Bio Solutions, visit http://ibs.inc/

Contact:
Spiro Sakiris, Chief Financial Officer
646-828-8258

SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.